University of Bern, Silence Therapeutics describe nucleic acids inhibiting PROS1 Nov. 30, 2020 No Comments
FDA complete response letter for sutimlimab cites third-party manufacturing issues Nov. 16, 2020 No Comments
Rallybio begins phase I/II study of RLYB-211 for fetal and neonatal alloimmune thrombocytopenia Nov. 11, 2020 No Comments
Adakveo approved in Europe to prevent VOCs in patients with sickle cell disease Nov. 4, 2020 No Comments
RSS